Ticker Details
Exagen Inc.
IPO Date:	September 20, 2019
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$77.28M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 3.67%
Avg Daily Range (30 D):	$0.17 | 3.87%
Avg Daily Range (90 D):	$0.17 | 2.69%

Institutional Daily Volume
Avg Daily Volume:	.08M
Avg Daily Volume (30 D):	.58M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	103
Avg Trade Size (Sh.) (30 D):	113
Avg Trade Size (Sh.) (90 D):	87

Institutional Trades
Total Institutional Trades:	72
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$1.4M
Avg Institutional Trade (90 D):	$1.91M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.31M
Avg Closing Trade (30 D):	$4.2M
Avg Closing Trade (90 D):	$4.2M
Avg Closing Volume:	215.46K

News

Feb 24, 2026 @ 2:00 PM Exagen Inc. to Announce Fourth Quarter and Full Ye... Source: Na

Jan 11, 2026 @ 8:00 PM Exagen Inc. Announces Select Preliminary 2025 Fina... Source: Na

Nov 11, 2025 @ 2:00 PM Exagen Inc. to Participate in Fourth Quarter Inves... Source: Ryan Douglas

Jun 13, 2024 @ 12:50 PM Why Fast-paced Mover Exagen (XGN) Is a Great Choic... Source: Zacks Equity Research

Jun 10, 2024 @ 12:03 PM Time to Play 5 Top-Ranked Stocks With Rising P/E? Source: Sanghamitra Saha

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.92	$-.31	$-.21
Diluted EPS	$-.92	$-.31	$-.21
Revenue	$63.6M	$17.24M	$17.2M
Gross Profit	$38.07M	$10.08M	$10.4M
Net Income / Loss	$-19.04M	$-7.09M	$-4.44M
Operating Income / Loss	$-12.48M	$-3.1M	$-2.63M
Cost of Revenue	$25.53M	$7.17M	$6.81M
Net Cash Flow	$13.62M	$5.62M	$18.84M
PE Ratio